Journal of Shandong University (Health Sciences) ›› 2023, Vol. 61 ›› Issue (2): 141-144.doi: 10.6040/j.issn.1671-7554.0.2022.0879
• 病例报道 • Previous Articles Next Articles
CLC Number:
| [1] DI Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques[J]. Hum Reprod Update, 2008, 14(2): 101-119. [2] Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine myomas: a review[J]. Int J Fertil Steril, 2016, 9(4): 424-435. [3] Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future[J]. Hum Reprod Update, 2016, 22(6): 665-686. [4] 张慧英, 薛凤霞. 子宫肌瘤的分型及临床决策 [J]. 中国实用妇科与产科杂志, 2019, 35(8): 857-860. ZHANG Huiying, XUE Fengxia. Classification of uterine fibroids and strategy of clinical treatment[J]. Acta Metallurgica Sinica, 2019, 35(8): 857-860. [5] 子宫肌瘤的诊治中国专家共识专家组. 子宫肌瘤的诊治中国专家共识 [J]. 中华妇产科杂志, 2017, 52(12): 793-800. [6] Yong J, Guo X, Lan H, et al. Clinical analysis of the MyoSure hysteroscopic tissue removal system of endometrial polyps in women with an intact hymen[J]. BMC Womens Health, 2021, 21(1): 214. doi:10.1186/S12905-021-01362-w. [7] 李丹, 万亚军. Myosure宫腔镜组织切除系统治疗宫内病变74例分析[J]. 实用妇产科杂志, 2016, 32(3): 208-211. LI Dan, WAN Yajun. Clinical analysis of 74 patients with intrauterine disease undergoing myosure hysteroscopic tissue removal system[J]. Journal of Practical Obstetrics and Gynecology, 2016, 32(3): 208-211. [8] 蒋建发, 万亚军, 薛敏. Myosure宫腔镜组织切除系统治疗无性生活子宫黏膜下肌瘤6例[J]. 中国微创外科杂志, 2019, 19(3): 278-280. [9] 李晴晴, 王晓东, 韩璐. 宫腔镜电切术治疗无性生活女性黏膜下肌瘤4例[J]. 中国微创外科杂志, 2016, 16(7): 648-649, 660. LI Qingqing, WANG Xiaodong, HAN Lu. Hysteroscopic resection for submucous myoma of uterus in 4 patients without sexual experience[J]. Chinese Journal of Minimally Invasive Surgery, 2016, 16(7): 648-649, 660. [10] 余凡, 曾俐琴, 罗喜平, 等. 新型宫腔镜旋切装置MyoSure在治疗宫腔病变中的应用 [J]. 中国妇幼保健, 2019, 34(12): 2871-2874. [11] 周琴琴, 倪美娣, 金群俏. 美奥舒宫腔组织切除系统治疗宫腔妊娠物残留的临床价值分析 [J]. 中国妇幼保健, 2020, 35(5): 957-959. [12] 孙冬岩, 王燕, 姚冬梅, 等. 美奥舒组织切除系统治疗宫内良性占位病变的临床分析 [J]. 现代妇产科进展, 2017, 26(6): 463-464, 467. [13] 卢艳, 崔超美, 李雪英. 美奥舒宫腔内组织切除系统在产后胎盘残留的临床应用价值[J]. 湖南师范大学学报(医学版), 2017, 14(3): 46-48. LU Yan, CUI Chaomei, LI Xueying. The clinical application value of using myosure hysteroscopic tissue removal system to postpartum placenta remnants[J]. Journal of Hunan Normal University(Medical Science), 2017, 14(3): 46-48. [14] Liang Y, Ren Y, Wan Z, et al. Clinical evaluation of improved MyoSure hysteroscopic tissue removal system for the resection of type II submucosal myomas[J]. Medicine(Baltimore), 2017, 96(50): e9363. doi:10.1097/MD.0000000000009363. [15] Van Dongen H, Emanuel MH, Wolterbeek R, et al. Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training[J]. J Minim Invasive Gynecol, 2008, 15(4): 466-471. [16] Salari BW, Bhagavath B, Galloway ML, et al. Hysteroscopic morcellator to overcome cervical stenosis[J]. Fertil Steril, 2016, 106(6): e12-e13. [17] Haber K, Hawkins E, Levie M, et al. Hysteroscopic morcellation: review of the manufacturer and user facility device experience(MAUDE)database[J]. J Minim Invasive Gynecol, 2015, 22(1): 110-114. [18] Noventa M, Ancona E, Quaranta M, et al. Intrauterine morcellator devices: the icon of hysteroscopic future or merely a marketing image? A systematic review regarding safety, efficacy, advantages, and contraindications[J]. Reprod Sci, 2015, 22(10): 1289-1296. [19] YIN X, Cheng J, Ansari SH, et al. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis[J]. Facts Views Vis Obgyn, 2018, 10(4): 207-213. |
| [1] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 93-94. |
| [2] | LU Zhenzhen, YAN Lei, ZHANG Hui, ZHANG Xiaohui, ZHAO Xingbo. Effects of TGF β-1 on the activation of endometrial stromal cells in tumor microenvironment [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 37-40. |
| [3] | ZHANG Xiaohui, YAN Lei, QI Shasha, LU Zhenzhen, LI Mingjiang, ZHAO Xingbo. Occurrence of epithelia-mesenchymal transition in endometrial adenocarci-noma and the roles of miR200a/ZEB1 signaling pathway in this process [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 48-52. |
| [4] |
LIU Jian-meng， CUI Bao-xia， YIN Ting， ZHANG Ai-rong.
Expression and significance of pigment epithelium-derived factor in cervix squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 103-106. |
| [5] | SU Shan1, KAN Yanyan1， TIAN Yongjie2. Expressions and significances of sFRP-1 and Wnt-1 in cervical carcinoma and precancerous lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 97-101. |
| [6] | YAN Lei, CHEN Zijiang. Treatment of adenomyosis complicated with infertility [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 43-47. |
| [7] | WANG Guoyun, PAN Zangyu. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55. |
| [8] | LENG Jinhua, SHI Jinghua. Clinical manifestations of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 1-5. |
| [9] | ZHANG Xinmei, XU Ping. Surgical treatment strategies of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 26-31. |
| [10] | GUO Sunwei, LIU Xishi. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19. |
| [11] | YU Mei, YANG Jiaxin, CAO Dongyan, WANG Yao, SHEN Keng. Diagnosis and management in patients with recurrent stage I endometrial cancer after primary fertility-preserving treatment [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 23-29. |
| [12] | PENG Chao, ZHOU Yingfang. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25. |
| [13] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 125-128. |
| [14] | YI Xiaofang, HUANG Jihua. Patient education and proper management of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 32-35. |
| [15] | . [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 118-120. |
|
||
